| Literature DB >> 30347682 |
Andreu Nolasco1, Pamela Pereyra-Zamora2, Elvira Sanchis-Matea3, Nayara Tamayo-Fonseca4, Pablo Caballero5, Inmaculada Melchor6,7, Joaquín Moncho8.
Abstract
Background: Both overall mortality and avoidable mortality have decreased in recent years in most European countries. It has become clear that less privileged socioeconomic groups have an increased risk of death. In 2008, most countries went into a severe economic recession, whose effects on the health of the population are still ongoing. While on the one hand, some evidence associates the economic crisis with positive health outcomes (pro-cyclical effect), on the other hand, some other evidence suggests that the economic crisis may pose serious public health problems (counter-cyclical effect), which has given rise to controversy.Entities:
Keywords: Spain; amenable mortality; economic recession; mortality; socioeconomic factors
Mesh:
Year: 2018 PMID: 30347682 PMCID: PMC6211017 DOI: 10.3390/ijerph15102298
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
ICD-10 classification code and age range for the amenable causes studied.
| Cause | ICD-10 | Age | |
|---|---|---|---|
| 1 | Intestinal infections | A00-09 | 0–14 |
| 2 | Tuberculosis | A15-A19, B90 | 0–74 |
| 3 | Other infections (diphtheria, tetanus, poliomyelitis) | A36, A35, A80 | 0–74 |
| 4 | Whooping cough | A37 | 0–14 |
| 5 | Septicaemia | A40-A41 | 0–74 |
| 6 | Measles | B05 | 1–14 |
| 7 | Malignant neoplasm of colon and rectum | C18-C21 | 0–74 |
| 8 | Malignant neoplasm of skin | C44 | 0–74 |
| 9 | Malignant neoplasm of breast | C50 | 0–74 |
| 10 | Malignant neoplasm of cervix uteri | C53 | 0–74 |
| 11 | Malignant neoplasm of cervix uteri and body uterus | C54-C55 | 0–44 |
| 12 | Malignant neoplasm of testis | C62 | 0–74 |
| 13 | Hodgkin’s disease | C81 | 0–74 |
| 14 | Leukaemia | C91-C95 | 0–44 |
| 15 | Diseases of the thyroid | E00-E07 | 0–74 |
| 16 | Diabetes | E10-E14 | 0–49 |
| 17 | Epilepsy | G40-G41 | 0–74 |
| 18 | Chronic rheumatic heart disease | I05-I09 | 0–74 |
| 19 | Hypertensive disease | I10-I13, I15 | 0–74 |
| 20 | Ischaemic heart disease: 50% of deaths | I20-I25 | 0–74 |
| 21 | Cerebrovascular disease | I60-I69 | 0–74 |
| 22 | All respiratory diseases | J00-J09, J20-J99 | 1–14 |
| 23 | Influenza | J10-J11 | 0–74 |
| 24 | Pneumonia | J12-J18 | 0–74 |
| 25 | Peptic ulcer | K25-K27 | 0–74 |
| 26 | Appendicitis | K35-K38 | 0–74 |
| 27 | Abdominal hernia | K40-K46 | 0–74 |
| 28 | Cholelithiasis and cholecystitis | K80-K81 | 0–74 |
| 29 | Nephritis and nephrosis | N00-N07N17-N19N25-N27 | 0–74 |
| 30 | Benign prostatic hyperplasia | N40 | 0–74 |
| 31 | Maternal death | O00-O99 | All |
| 32 | Congenital cardiovascular anomalies | Q20-Q28 | 0–74 |
| 33 | Perinatal deaths | P00-P96, A33, A34 | All |
| 34 | Misadventures to patients | Y60-Y69, Y83-Y84 | All |
ICD: International Statistical Classification of Diseases.
Spearman’s rank correlation coefficient $ between the indicators of the impact of the crisis and the relative decreases in overall and amenable mortality.
| Cause of Death | Real-Estate Vulnerability | Economic Vulnerability | Social Vulnerability | Total Vulnerability | |
|---|---|---|---|---|---|
|
| |||||
| Overall mortality | Rho | 0.441 * | 0.502 * | 0.017 | 0.468 * |
| Sig. | (0.001) | (0.001) | (0.904) | (0.001) | |
| Total amenable mortality | Rho | 0.166 | 0.323 * | 0.053 | 0.242 |
| Sig. | (0.239) | (0.020) | (0.708) | (0.084) | |
| Cancer (causes 7 to 14) | Rho | 0.162 | 0.231 | 0.111 | 0.204 |
| Sig. | (0.252) | (0.100) | (0.433) | (0.147) | |
| Ischaemic heart disease | Rho | 0.135 | 0.096 | −0.192 | 0.061 |
| (cause 20) | Sig. | (0.340) | (0.500) | (0.173) | (0.666) |
| Cerebrovascular disease | Rho | 0.045 | 0.134 | 0.066 | 0.115 |
| (cause 21) | Sig. | (0.754) | (0.343) | (0.642) | (0.417) |
| Hypertensive disease | Rho | −0.122 | 0.011 | −0.281 * | −0.149 |
| (cause 19) | Sig. | (0.388) | (0.938) | (0.044) | (0.290) |
| Other causes | Rho | 0.015 | 0.160 | 0.006 | 0.078 |
| Sig. | (0.916) | (0.256) | (0.964) | (0.581) | |
|
| |||||
| Overall mortality | Rho | 0.360 * | 0.340 * | 0.102 | 0.382 * |
| Sig. | (0.009) | (0.014) | (0.473) | (0.005) | |
| Amenable mortality | Rho | 0.445 * | 0.295 * | −0.087 | 0.350 * |
| Sig. | (0.001) | (0.034) | (0.538) | (0.011) | |
| Cancer (causes 7 to 14) | Rho | 0.232 | 0.194 | 0.210 | 0.257 |
| Sig. | (0.097) | (0.168) | (0.134) | (0.066) | |
| Ischaemic heart disease | Rho | 0.130 | 0.174 | −0.037 | 0.138 |
| (cause 20) | Sig. | (0.358) | (0.218) | (0.795) | (0.330) |
| Cerebrovascular disease | Rho | 0.473 * | 0.316 * | −0.046 | 0.403 * |
| (cause 21) | Sig. | (0.001) | (0.022) | (0.745) | (0.003) |
| Hypertensive disease | Rho | 0.054 | 0.126 | −0.230 | 0.006 |
| (cause 19) | Sig. | (0.704) | (0.372) | (0.100) | (0.966) |
| Other amenable causes | Rho | 0.004 | −0.064 | −0.378 * | −0.133 |
| Sig. | (0.979) | (0.654) | (0.006) | (0.348) | |
$ In brackets: statistical significance value for zero correlation hypothesis testing. * Statistical significance (p < 0.05). Rho = Spearman’s rank correlation coefficient. Sig. = Significant.
(a)
| Overall Mortality | Amenable Mortality (Total) | |||||
|---|---|---|---|---|---|---|
| ASR $ | ASR | ΔASR # | AASR $ | AASR | ΔAASR # | |
|
| ||||||
| Spain | 958.23 | 819.92 | 14.43 | 81.84 | 66.08 | 19.26 |
| Provinces | ||||||
| Average | 944.79 | 819.32 | 13.24 | 81.18 | 66.81 | 17.61 |
| Standard deviation | 90.86 | 77.97 | 2.26 | 12.13 | 10.22 | 4.54 |
| Minimum value | 770.14 | 681.12 | 8.36 | 61.83 | 51.97 | 3.91 |
| Maximum value | 1140.38 | 997.28 | 18.96 | 112.2 | 95.15 | 26.20 |
| Coefficient of variation (%) | 9.61 | 9.52 | 17.07 | 14.94 | 15.3 | 25.78 |
|
| ||||||
| Spain | 860.37 | 753.03 | 12.48 | 59.58 | 49.13 | 17.54 |
| Provinces | ||||||
| Average | 861.24 | 758.64 | 11.83 | 60.03 | 49.95 | 16.35 |
| Standard deviation | 99.31 | 83.83 | 2.35 | 10.9 | 8.27 | 5.63 |
| Minimum value | 719.62 | 632.16 | 6.48 | 42.07 | 36.53 | −1.51 |
| Maximum value | 1104.90 | 1024.91 | 16.96 | 94.68 | 79.99 | 29.50 |
| Coefficient of variation (%) | 11.53 | 11.05 | 19.87 | 18.16 | 16.56 | 34.43 |
ΔAASR # (% decrease) by group of amenable causes.
(b)
| Cancer | Ischaemic Heart Disease | Cerebrovascular Disease | Hypertensive Disease | Other Causes | |
|---|---|---|---|---|---|
| (Causes 7 to 14) | (Cause 20) | (Cause 21) | (Cause 19) | ||
|
| |||||
| Spain | 0.79 | 25.84 | 29.07 | −2.26 | 22.65 |
| Provinces | |||||
| Average | −3.41 | 23.88 | 26.84 | −8.24 | 22.15 |
| Standard deviation | 19.42 | 46.62 | 6.84 | 33.66 | 9.48 |
| Minimum value | −123.50 | 6.83 | 12.08 | −156.76 | −1.12 |
| Maximum value | 27.39 | 9.79 | 38.11 | 66.67 | 45.68 |
| Coefficient of variation (%) | 569.50 | 28.60 | 25.48 | 408.49 | 42.79 |
|
| |||||
| Spain | 8.14 | 30.69 | 28.90 | 16.75 | 22.03 |
| Provinces | |||||
| Average | 6.07 | 29.28 | 25.03 | 13.98 | 22.28 |
| Standard deviation | 8.20 | 12.78 | 13.95 | 28.84 | 10.62 |
| Minimum value | −17.26 | −23.41 | −35.51 | −84.91 | −4.95 |
| Maximum value | 22.86 | 163.43 | 43.87 | 60.40 | 49.97 |
| Coefficient of variation (%) | 135.10 | 43.65 | 55.73 | 206.29 | 47.67 |
$ ASR = Overall Mortality Age Standardised Rate; AASR = Amenable Mortality Age Standardised Rate. Standard Population: The sum of the populations during the period 2002–2013. # ΔASR = Percentage decrease in ASR between 2002–2007 and 2008–2013; ΔAASR = Percentage decrease in AASR between 2002–2007 and 2008–2013.